| |
| |
|
| Insider
Information: |
Kelsey Stephen Michael |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
354,181 |
|
|
Indirect Shares
|
31,134 |
|
|
| Direct
Value |
$10,355,739 |
|
|
|
Indirect Value
|
$114,573 |
|
|
| Total
Shares |
385,315 |
|
|
| Total
Value |
$10,470,313 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.3
|
| Percentage
Gain/Loss : |
0.0%
|
 88.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Geron Corporation |
GERN |
EVP, R&D, Chief Med Of... |
2013-05-03 |
62,272 |
2012-12-31 |
31,134 |
Premium* |
|
|
Medivation Inc |
MDVN |
SVP of New Projects |
2014-02-04 |
21,000 |
2013-06-13 |
0 |
Premium* |
|
|
Revolution Medicines, Inc. |
RVMD |
|
2024-03-18 |
270,909 |
2020-08-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GERN |
Geron Corporation |
EVP, CMO, Oncology |
• – – |
2010-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
73,793 |
0 |
- |
|
| GERN |
Geron Corporation |
EVP, CMO, Oncology |
• – – |
2010-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
376,136 |
0 |
- |
|
| GERN |
Geron Corporation |
EVP, CMO, Oncology |
• – – |
2010-12-31 |
5 |
A |
$4.11 |
$8,869 |
D/D |
2,158 |
378,294 |
0 |
- |
|
| GERN |
Geron Corporation |
EVP, R&D Head, CMO |
• – – |
2011-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
117,500 |
481,631 |
0 |
- |
|
| GERN |
Geron Corporation |
EVP, R&D Head, CMO |
• – – |
2011-06-30 |
5 |
A |
$3.41 |
$10,002 |
D/D |
2,933 |
479,706 |
0 |
- |
|
| GERN |
Geron Corporation |
EVP, R&D Head, CMO |
• – – |
2011-12-31 |
5 |
A |
$1.26 |
$3,422 |
D/D |
2,716 |
482,422 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP of New Projects |
• – – |
2013-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
0 |
- |
|
| MDVN |
Medivation Inc |
SVP of New Projects |
• – – |
2014-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
21,000 |
0 |
- |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
252,073 |
0 |
- |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,800 |
290,615 |
0 |
- |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
327,599 |
0 |
- |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
51,400 |
273,032 |
0 |
- |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-08-12 |
4 |
AS |
$25.79 |
$261,694 |
D/D |
(10,100) |
268,009 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-08-13 |
4 |
AS |
$27.40 |
$134,995 |
D/D |
(4,900) |
268,009 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-08-27 |
4 |
AS |
$29.01 |
$46,825 |
D/D |
(1,614) |
267,195 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-08-28 |
4 |
AS |
$29.00 |
$3,422 |
D/D |
(118) |
267,195 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-01 |
4 |
AS |
$26.43 |
$276,722 |
D/D |
(10,000) |
267,195 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-02 |
4 |
AS |
$29.02 |
$23,973 |
D/D |
(826) |
266,469 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-03 |
4 |
AS |
$29.06 |
$40,699 |
D/D |
(1,400) |
265,769 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-08 |
4 |
AS |
$29.02 |
$40,683 |
D/D |
(1,400) |
264,969 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-09 |
4 |
AS |
$29.04 |
$2,904 |
D/D |
(100) |
264,869 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-10 |
4 |
AS |
$29.00 |
$73,880 |
D/D |
(2,542) |
263,329 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-17 |
4 |
AS |
$31.03 |
$352,556 |
D/D |
(11,363) |
251,966 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-18 |
4 |
AS |
$31.03 |
$19,767 |
D/D |
(637) |
251,329 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
See Remarks |
• – – |
2020-09-21 |
4 |
AS |
$33.00 |
$491,805 |
D/D |
(14,902) |
236,427 |
0 |
% |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
